SPRIM Tackles Peanut Allergy via Prota Therapeutics
18 Jan 2024
US$ 19.00
Singapore-based SPRIM Global Investments (SGI) has led the US$21 million equity and debt financing of Prota...
Tag
Biotech
Related Publications
Subscribers’ Weekly for the week ending 1 May 2026...
Listen to Subscribers' Weekly 01 May 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.